Page last updated: 2024-09-03

1'-acetoxychavicol acetate and Bone Loss, Osteoclastic

1'-acetoxychavicol acetate has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katsumata, S; Murakami, A; Ohigashi, H; Song, M; Suzuki, K; Uehara, M1
Aggarwal, BB; Ichikawa, H; Murakami, A1

Other Studies

2 other study(ies) available for 1'-acetoxychavicol acetate and Bone Loss, Osteoclastic

ArticleYear
Citrus nobiletin suppresses bone loss in ovariectomized ddY mice and collagen-induced arthritis in DBA/1J mice: possible involvement of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis regulation.
    BioFactors (Oxford, England), 2007, Volume: 30, Issue:3

    Topics: Animals; Antioxidants; Arthritis, Experimental; Benzyl Alcohols; Blotting, Western; Bone Density; Bone Resorption; Cell Line; Citrus; Coumarins; Female; Flavones; Isothiocyanates; Mice; Mice, Inbred DBA; Molecular Structure; Osteogenesis; Ovariectomy; RANK Ligand; Sesquiterpenes; Terpenes

2007
1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
    Molecular cancer research : MCR, 2006, Volume: 4, Issue:4

    Topics: Animals; Benzyl Alcohols; Bone Resorption; Carrier Proteins; Cell Differentiation; Down-Regulation; Humans; I-kappa B Kinase; Membrane Glycoproteins; Mice; Monocytes; Neoplasms; NF-kappa B; Osteoclasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Terpenes; Tumor Cells, Cultured

2006